Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 14 February 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Most common indications for liver transplantation in Europe

Hepatocellular carcinoma-related chronic liver disease is one of the most common indications for liver transplantation in Europe, reports the most recent issue of the Journal of Hepatology.

News image

Hepatocellular carcinoma-related chronic liver disease is one of the most common indications for liver transplantation in Europe.

The ELTR database was used to evaluate outcomes and evolution over 20years.

Dr Patrizia Burra and colleagues analyzed 16,664 hepatocellular carcinoma transplanted patients according to indication for liver transplantation, as decompensated cirrhosis or hepatocellular carcinoma.

These groups were compared with co-infected patients decompensated cirrhosis or hepatocellular carcinoma, decompensated cirrhosis or hepatocellular carcinoma.

The researchers noted that 5912 patients were transplanted for hepatocellular carcinoma, with decompensated cirrhosis or hepatocellular carcinoma patients who increased from 16% in 1988–1995 to 30% in 2006–2010.

In hepatocellular carcinoma patients, 1 year patient survival was 83%
Journal fo Hepatology

In hepatocellular carcinoma patients, 1, 3, 5, and 10year patient and graft survival was 83%, 78%, 75%, 68%, and 80%, 74%, 71%, 64%, respectively, significantly better than decompensated cirrhosis or hepatocellular carcinoma.

The team of doctors assessed that in 2006–2010 patient and graft survival significantly improved compared to 1988–1995, both for HBV and decompensated cirrhosis or hepatocellular carcinoma.

A better patient and graft survival was seen in decompensated cirrhosis or hepatocellular carcinoma patients with hepatocellular carcinoma-DNA(−) compared to hepatocellular carcinoma-DNA(+) at the time of liver transplantation.

The researchers examined that disease recurrence, as cause of death/graft loss, was significantly reduced in recent years compared to the past.

Currently 1% for hepatocellular carcinoma, and 3% for decompensated cirrhosis or hepatocellular carcinoma.

Dr Burra's team concludes, "Outcomes of liver transplantation for HBV have improved in recent years, with disease recurrence being no longer a significant cause of death/graft loss."

"Hepatocellular carcinoma-DNA at the time of liver transplantation seems to influence survival only in decompensated cirrhosis or hepatocellular carcinoma patients."

J Hepatol 2013 (58)2 :287-296
21 February 2013

Go to top of page Email this page Email this page to a colleague

 12 February 2016 
Colorectal cancer after negative signoidoscopy
 12 February 2016 
Genetic factors and response to glucocorticoids in IBD
 12 February 2016 
Tobacco smoking and the natural history of Crohn’s
 11 February 2016 
Colorectal surgery training
 11 February 2016 
Liver disease unique to pregnancy
 11 February 2016 
Serous cystic neoplasm 
 10 February 2016 
NAFLD in Veterans in the USA
 10 February 2016 
Rectosigmoidoscopy vs colonoscopy in ulcerative colitis
 10 February 2016 
Liver cancer and primary biliary cirrhosis
 09 February 2016 
Bowel preparation for colonoscopy screening
 09 February 2016 
Eosinophilic esophagitis and parental allergies
 09 February 2016 
Cancer-specific prognosis in octogenarians with colorectal cancer
 08 February 2016 
Cancelled colonoscopy appointments
 08 February 2016 
Cognitive function in Crohn's disease
 08 February 2016 
Immunity in the human gut
 05 February 2016 
Treatment for ileal pouch-anal anastomosis for Crohn’s colitis
 05 February 2016 
Helicobacter cinaedi bacteremia
 05 February 2016 
Methotrexate and remission in ulcerative colitis
 04 February 2016 
Diabetes and liver cancer
 04 February 2016 
Colorectal cancer screening
 04 February 2016 
H. pylori and coronary heart disease 
 03 February 2016 
Acute diverticulitis and IBS 
 03 February 2016 
Microbiota of the colonic mucosa and chronic constipation
 03 February 2016 
Guidelines for chronic pancreatitis
 02 February 2016 
Ramosetron and IBS-diarrhea
 02 February 2016 
IBD emergency department visits
 02 February 2016 
Probiotics for H. pylori management
 01 February 2016 
Managing HBV in pregnancy
 01 February 2016 
Depressive symptoms in IBD 
 01 February 2016 
Obesity and hepatocellular carcinoma risk
 29 January 2016 
Colorectal cancer after colonoscopy
 29 January 2016 
Acute diverticulitis in immunosuppressed patients
 29 January 2016 
Vitamin D and colorectal cancer risk
 28 January 2016 
Tissue anti-TNF drug levels and IBD
 28 January 2016 
First line treatment of H. pylori infection
 28 January 2016 
Tetracycline for rosacea increases the risk of IBD
 27 January 2016 
Steroids in children with Crohn's
 27 January 2016 
Self-management IBS program 
 27 January 2016 
Human gut microbiome in IBD 
 26 January 2016 
Smoking and symptomatic diverticular disease
 26 January 2016 
Step-down therapy in PPI-responsive esophageal eosinophilia 
 26 January 2016 
Diet and IBD risk
 25 January 2016 
IBD monitoring using smartphones
 25 January 2016 
Self-management IBS program
 25 January 2016 
Colorectal cancer after a negative screening sigmoidoscopy
 22 January 2016 
Length of Barrett's and cancer
 22 January 2016 
Psychosocial interventions and alcohol abstinence in chronic liver disease
 22 January 2016 
Helicobacter pylori antibiotic resistance
 21 January 2016 
Increasing adenoma detection rate during colonoscope withdrawal
 21 January 2016 
Microscopic colitis current concepts
 21 January 2016 
Statins as a management strategy for constipation 
 20 January 2016 
Health status after bariatric surgery
 20 January 2016 
Hep E infection in West Africa
 20 January 2016 
Preventing endoscopic bacterial transmission
 19 January 2016 
PPIs and phlebotomy in hereditary hemochromatosis
 19 January 2016 
Predicting liver cirrhosis in Hep C
 19 January 2016 
Frozen vs fresh fecal microbiota transplantation
 18 January 2016 
Hospitalization for diverticulitis in the USA
 18 January 2016 
H. pylori and gastric cancer across Europe
 18 January 2016 
Enteral nutrition in children with Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us